EE111 Budget Impact of Nivolumab Plus Ipilimumab Plus Chemotherapy as First-Line Treatment for Patients With Metastatic Non-Small Cell Lung Cancer in Switzerland
Abstract
Authors
Nicole Graf Diana Teloian Aastha Jain Johan Maervoet César Oniangue-Ndza